The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Traktirskaya O.A.

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, Moscow, Russia

Popova E.V.

City Clinical Hospital No. 24 of Moscow;
Pirogov Russian National Research University

Latsh N.Yu.

Pirogov National Research Medical University

Adasheva T.V.

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, Moscow, Russia

Boyko A.N.

N.I. Pirogov Russian National Research Medical University;
Federal Center for Cerebrovascular Pathology and Stroke

Comorbid pathology of the cardiovascular system in young patients with relapsing-remitting multiple sclerosis

Authors:

Traktirskaya O.A., Popova E.V., Latsh N.Yu., Adasheva T.V., Boyko A.N.

More about the authors

Read: 3153 times


To cite this article:

Traktirskaya OA, Popova EV, Latsh NYu, Adasheva TV, Boyko AN. Comorbid pathology of the cardiovascular system in young patients with relapsing-remitting multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(10‑2):72‑80. (In Russ.)
https://doi.org/10.17116/jnevro201911910272

Recommended articles:
The possibilities of Mexi­dol in the complex therapy of arte­rial hype­rtension. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(5):572-580
The significance of exogenous nitrate and nitrite of plant origin for vascular health. Russian Journal of Preventive Medi­cine. 2024;(11):141-146
Surgical treatment of seco­ndary trigeminal neuralgia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):203-209
Quality of life of patients with multiple scle­rosis in the Smolensk region. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):36-40

References:

  1. Thompson AJ, Baranzini SE, Geurts J. Hemmer B, Ciccarelli O. Multiple sclerosis. Lancet. 2018;391(10130):1622-1636. https://doi.org/10.1016/S0140-6736(18)30481-1
  2. Goodin DS. The epidemiology of multiple sclerosis: insights to a causal cascade. Handb Clin Neurol. 2016;138:173-206. https://doi.org/10.1016/B978-0-12-802973-2.00011-2
  3. Thompson AJ, Uitdehaag B, Taylor B, Holloway E, Tremlett H, Pandit L, Battaglia M. Atlas of MS 2013. London: Multiple Sclerosis International Federation; 2013. Date of the application: 04.02.19 https://www.msif.org/wpcontent/uploads/2014/09/Atlas-of-MS.pdf
  4. Kobelt G, Thompson A, Berg J, Gannedahl M, Eriksson J; MSCOI Study Group; European Multiple Sclerosis Platform. New insights into the burden and costs of multiple sclerosis in Europe. Mult Scler. 2017;23(8):1123-1136. https://doi.org/10.1177/1352458517694432
  5. Boyko A, Kobelt G, Berg J, Boyko O, Popova E, Capsa D, Eriksson J, The European Multiple Sclerosis Platform. New insights into the burden and costs of multiple sclerosis in Europe: Results for Russia. Mult Sler. 2017;23(2):155-165. https://doi.org/10.1177/1352458517708668
  6. Hobart J, Bowen A, Pepper G, Crofts H, Eberhard L, Berger T, Boyko A, Boz C, Butzkueven H, Celius EG, Drulovic J, Flores J, Horáková D, Lebrun-Frénay C, Marrie RA, Overell J, Piehl F, Rasmussen PV, Sá MJ, Sîrbu CA, Skromne E, Torkildsen Ø, van Pesch V, Vollmer T, Zakaria M, Ziemssen T, Giovannoni G. International consensus on quality standards for brain health-focused care in multiple sclerosiss. Mult Scler. 2018;1:1352458518809326. https://doi.org/10.1177/1352458518809326
  7. Rieckmann P, Boyko A, Centonze D, Elovaara I, Giovannnoni G, Havrdová E, Hommes O, Kesselring J, Kobelt G, Langdon D, LeLorier J, Morrow SA, Oreja-Guevara C, Schippling S, Thalheim C. Achieving patient engagement in multiple sclerosis: A perspective from the multiple sclerosis in the 21st Century Steering Group. Multiple Sclerosis & Related Disorders. 2015;4(3):202-218. https://doi.org/10.1016/j.msard.2015.02.005
  8. Marrie RA. Comorbidity in multiple sclerosis: Past, present and future. Clin Invest Med. 2019;42(1):5-12. https://doi.org/10.25011/cim.v42i1.32383
  9. Kowalec K, McKay KA, Patten SB, Fisk JD, Evans C, Tremlett H, Marrie RA; CIHR Team in Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS). Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study. Neurology. 2017;89(24):2455-2461. https://doi.org/10.1212/WNL.0000000000004716
  10. Marrie RA, Elliott L, Marriott J, Cossoy M, Tennakoon A, Yu N. Comorbidity increases the risk of hospitalizations in multiple sclerosis. Neurology. 2015;84(4):350-358. https://doi.org/10.1212/WNL.0000000000001187
  11. Marrie RA, Reider N, Cohen J, Stuve O, Trojano M, Cutter G, Reingold S, Sorensen PS. A systematic review of the incidence and prevalence of cardiac, cerebrovascular and peripheral vascular disease in multiple sclerosis. Mult Scler J. 2015;21:318-331.
  12. Kaplan TB, Berkowitz AL, Samuels MA. Cardiovascular Dysfunction in Multiple Sclerosis. Neurologist. 2015;20(6):108-114. https://doi.org/10.1097/NRL.0000000000000064
  13. Jadidi E, Mohammadi M, Moradi T. High risk of cardiovascular diseases after diagnosis of multiple sclerosis. Mult Scler. 2013;19(10):1336-1340. https://doi.org/10.1177/1352458513475833
  14. Gusev EI, Boĭko AN, Kol’iak EV, Karalkin AV, Kamchatnov PR, Martynov MYu. The impact of microcirculation dysfunction on the clinical presentations of multiple sclerosis in patients above 45 years and the possible ways of correction of the vascular pathology. Zhurnal Nevrlogii i Psikhiatrii im. S.S. Korsakova. 2008;108(5):25-31. (In Russ.)
  15. Marrie RA, Fisk J, Tremlett H, Wolfson C, Warren S, Blanchard J, Patten SB; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis. Differing trends in the incidence of vascular comorbidity in MS and the general population. Neurol Clin Pract. 2016;6(2):120-128.
  16. Dubchenko EA, Boyko AN, Kol’iak EV, Pozidaeva NV. Arterial hypotension in patients with multiple sclerosis. Zhurnal nevrlogii i psikhiatrii im. S.S. Korsakova. 2017;117(10-2):65-66. (In Russ.)
  17. Marrie RA, Reider N, Cohen J, Stuve O, Trojano M, Cutter G, Reingold S, Sorensen PS. A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis. Mult Scler. 2015;21(3):318-331. https://doi.org/10.1177/1352458514564485
  18. Murray TJ. The cardiac effects of mitoxantrone: Do the benefits in multiple sclerosis outweigh the risks? Expert Opin Drug Saf. 2006;5:265-274. https://doi.org/10.1517/14740338.5.2.265
  19. Wei L, MacDonald TM, Walker BR. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med. 2004;141:764-770. https://doi.org/10.7326/0003-4819-141-10-200411160-00007
  20. Rossi S, Rocchi C, Studer V, Motta C, Lauretti B, Germani G, Macchiarulo G, Marfia GA, Centonze D. The autonomic balance predicts cardiac responses after the first dose of fingolimod. Mult Scler. 2015;21(2):206-216. https://doi.org/10.1177/1352458514538885
  21. Geraldes R, Esiri MM, DeLuca GC, Palace J. Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis. Brain Pathol. 2017;27(6):707-722. https://doi.org/10.1111/bpa.12460
  22. Jakimovski D, Gandhi S, Paunkoski I, Bergsland N, Hagemeier J, Ramasamy DP, Hojnacki D, Kolb C, Benedict RHB, Weinstock-Guttman B, Zivadinov R. Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5-year longitudinal study. Eur J Neurol. 2019;26(1):87-88. https://doi.org/10.1111/ene.13769
  23. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292-302. https://doi.org/10.1002/ana.22366
  24. Krasnikov GV, Tyurina MY, Tankanag AV. Piskunova GM, Chemeris NK. Analysis of heart rate variability and skin blood flow oscillations under deep controlled breathing. Respir Physiol Neurobiol. 2013;185(3):562-570. https://doi.org/10.1016/j.resp.2012.11.007
  25. Trifonova SS, Gaysenok OV, Sidorenko BA. Application of methods for assessing the stiffness of the vascular wall in clinical practice: the possibility of cardiovascular index. Cardiology. 2015;(4):55-61. (In Russ.) https://doi.org/10.18565/cardio.2015.4.61-66
  26. Hu CL, Lin ZS, Chen YY, Lin YH, Li ML. Portable laser Doppler flowmeter for microcirculation detection. Biomed Eng Letters. 2013;3(2):109-114. https://doi.org/10.1007/s13534-013-0095-x
  27. Wens I, Dalgas U, Stenager E, Eijnde BO. Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis — a systematic review. Mult Scler. 2013;19(12):1556-1564. https://doi.org/10.1177/1352458513504252
  28. Witte K, Engelhard S, Janssen BJ. Circadian and short-term regulation of blood pressure and heart rate in transgenic mice with cardiac over expression of the beta1-adrenoreceptor. Chronobiol Int. 2004;21(2):205-216. https://doi.org/10.1081/CBI-120037801
  29. Spirina NN, Spirin NN, Fadeeva OA, Shipova EG, Boiko AN. Multiple sclerosis and endothelial dysfunction. Zhurnal Nevrlogii i Psikhiatrii im. S.S. Korsakova. 2013;113(10-2):32-42. (In Russ.)
  30. Malpas SC. The rhythmicity of sympathetic nerve activity. Progress in Neurobiology. 1998;56:65-96. https://doi.org/10.1016/S0301-0082(98)00030-6
  31. Guild SJ, Barrett CJ, McBryde FD, Van Vliet BN, Head GA, Burke SL, Malpas SC. Quantifying sympathetic nerve activity: problems, pitfalls and the need for standardization. Exp Physiol. 2010;95:41-50. https://doi.org/10.1113/expphysiol.2008.046300
  32. Bi R, Dong J, Poh CL, Lee K. Optical methods for blood perfusion measurement — theoretical comparison among four different modalities. J Opt Soc Amer A. 2015;32(5):860-866. https://doi.org/10.1364/JOSAA.32.000860
  33. Meyer C, de Vries G, Davidge S, Mayes DC. Reassessing the mathematical modeling of the contribution of vasomotion to vascular resistance. J Appl Physiol. 2002;92:888-889. https://doi.org/10.1152/jappl.2002.92.2.888
  34. Motl RW, Arnett PA, Smith MM, Barwick FH, Ahlstrom B, Stover EJ. Worsening of symptoms is associated with lower physical activity levels in individuals with multiple sclerosis. Mult Scler. 2008;14:140-142. https://doi.org/10.1177/1352458507079126
  35. Karlov VA. Multiple sclerosis. Terapia nervnich bolezney. M.: Medicina; 1987. (In Russ.)
  36. Spencer JI, Bell JS, DeLuca GC. Vascular pathology in multiple sclerosis: reframing pathogenesis around the blood-brain barrier. J Neurol Neurosurg Psychiatry. 2018;89(1):42-52. https://doi.org/10.1136/jnnp-2017-316011
  37. Hong Y, Tang HR, Ma M, Chen N, Xie X, He L. Multiple sclerosis and stroke: a systematic review and meta-analysis. BMC Neurol. 2019;19(1):139. https://doi.org/10.1186/s12883-019-1366-7

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.